Literature DB >> 12228235

Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.

Yukiko Kitagawa1, Kaoru Inoue, Shigeru Sasaki, Yasuhide Hayashi, Yoshinobu Matsuo, Michael R Lieber, Hideaki Mizoguchi, Jun Yokota, Takashi Kohno.   

Abstract

To understand molecular pathways underlying 9p21 deletions, which lead to inactivation of the p16/CDKN2A, p14/ARF, and/or p15/CDKN2B genes, in lymphoid leukemia, 30 breakpoints were cloned from 15 lymphoid leukemia cell lines. Seventeen (57%) breakpoints were mapped at five breakpoint cluster sites, BCS-LL1 to LL5, each of <15 bp. Two breakpoint cluster sites were located within the ARF and CDKN2B loci, respectively, whereas the remaining three were located >100 kb distal to the CDKN2A, ARF, and CDKN2B loci. The sequences of breakpoint junctions indicated that deletions in the 11 (73%) cell lines were mediated by illegitimate V(D)J recombination targeted at the five BCS-LL and six other sites, which contain sequences similar to recombination signal sequences for V(D)J recombination. An extrachromosomal V(D)J recombination assay indicated that BCS-LL3, at which the largest number of breakpoints (i.e. five breakpoints) was clustered, has a V(D)J recombination potential 150-fold less than the consensus recombination signal sequence. Three other BCS-LLs tested also showed V(D)J recombination potential, although it was lower than that of BCS-LL3. These results indicated that illegitimate V(D)J recombination, which was targeted at several ectopic recombination signal sequences widely distributed in 9p21, caused a large fraction of 9p21 deletions in lymphoid leukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228235     DOI: 10.1074/jbc.M208353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

Authors:  Amy L Sherborne; Fay J Hosking; Rashmi B Prasad; Rajiv Kumar; Rolf Koehler; Jayaram Vijayakrishnan; Elli Papaemmanuil; Claus R Bartram; Martin Stanulla; Martin Schrappe; Andreas Gast; Sara E Dobbins; Yussanne Ma; Eamonn Sheridan; Malcolm Taylor; Sally E Kinsey; Tracey Lightfoot; Eve Roman; Julie A E Irving; James M Allan; Anthony V Moorman; Christine J Harrison; Ian P Tomlinson; Sue Richards; Martin Zimmermann; Csaba Szalai; Agnes F Semsei; Daniel J Erdelyi; Maja Krajinovic; Daniel Sinnett; Jasmine Healy; Anna Gonzalez Neira; Norihiko Kawamata; Seishi Ogawa; H Phillip Koeffler; Kari Hemminki; Mel Greaves; Richard S Houlston
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

2.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

3.  Optimizing PCR assays for DNA-based cancer diagnostics.

Authors:  Ali Bashir; Qing Lu; Dennis Carson; Benjamin J Raphael; Yu-Tsueng Liu; Vineet Bafna
Journal:  J Comput Biol       Date:  2010-03       Impact factor: 1.479

Review 4.  Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.

Authors:  Masahiro Onozawa; Peter D Aplan
Journal:  Genes Chromosomes Cancer       Date:  2012-02-15       Impact factor: 5.006

5.  Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.

Authors:  Albert G Tsai; Haihui Lu; Sathees C Raghavan; Markus Muschen; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

Review 6.  Global genomic characterization of acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; James R Downing
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

Review 7.  Mechanisms of human lymphoid chromosomal translocations.

Authors:  Michael R Lieber
Journal:  Nat Rev Cancer       Date:  2016-05-25       Impact factor: 60.716

8.  Genetic variegation of clonal architecture and propagating cells in leukaemia.

Authors:  Kristina Anderson; Christoph Lutz; Frederik W van Delft; Caroline M Bateman; Yanping Guo; Susan M Colman; Helena Kempski; Anthony V Moorman; Ian Titley; John Swansbury; Lyndal Kearney; Tariq Enver; Mel Greaves
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962

9.  Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.

Authors:  Francesca Novara; Silvana Beri; Maria Ester Bernardo; Riccardo Bellazzi; Alberto Malovini; Roberto Ciccone; Angela Maria Cometa; Franco Locatelli; Roberto Giorda; Orsetta Zuffardi
Journal:  Hum Genet       Date:  2009-05-30       Impact factor: 4.132

10.  Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.

Authors:  Elisabeth P Nacheva; Diana Brazma; Anna Virgili; Julie Howard-Reeves; Anastasios Chanalaris; Katya Gancheva; Margarita Apostolova; Mikel Valgañon; Helen Mazzullo; Colin Grace
Journal:  BMC Genomics       Date:  2010-01-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.